Fundraising Fox
Cantoni
Leiden, NL · 9 employees on LinkedIn · 1 known investors
Find your way into Cantoni
Sign up to see every warm intro you have to Cantoni
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cantoni team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does Cantoni do?
- Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.
- Who founded Cantoni?
- Cantoni was founded by Matthijs van Haren, Nathaniel Martin.
- Who are Cantoni's investors?
- Cantoni's investors include BOM.
- Where is Cantoni headquartered?
- Cantoni is headquartered in Leiden, NL.